Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-19-016381
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-05 16:04:05
Reporting Period:
2019-03-01
Accepted Time:
2019-03-05 16:04:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc AGIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1533451 L. Steven Hoerter C/o Agios Pharmaceuticals
88 Sidney Street
Cambridge MA 02139
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-01 5,000 $39.76 15,941 No 4 M Direct
Common Stock Disposition 2019-03-01 5,000 $66.01 10,941 No 4 S Direct
Common Stock Acquisiton 2019-03-04 5,000 $39.76 15,941 No 4 M Direct
Common Stock Disposition 2019-03-04 5,000 $68.00 10,941 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2019-03-01 5,000 $0.00 5,000 $39.76
Common Stock Stock option (right to buy) Disposition 2019-03-04 5,000 $0.00 5,000 $39.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,650 2026-02-15 No 4 M Direct
50,650 2026-02-15 No 4 M Direct
Footnotes
  1. This option was granted on February 16, 2016. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter.